CROS NT has a strong CRO management team with a wealth of experience in the life sciences and clinical trials sector.

Gabriele Brambilla

Gabriele is passionate about healthcare innovation. In addition to his appointment as Alira Health CEO in 2014, he serves on the Board of Directors for leading-edge start-ups EnlightenVue, WoundForce, Firefly, and Computational Life.

In 2018, he co-founded the MetroWest Life Sciences Network to develop collaboration, innovation, and entrepreneurship in Bostons MetroWest life sciences ecosystem. Gabriele is a regular participant in global events as a moderator, speaker, and panelist.

Paolo Morelli, CEO CROS NT

Paolo is a passionate entrepreneur who has over 19 years of experience in the Life Sciences industry. He is involved as a scientific advisor in multiple technology innovation start-ups and is a member of leading industry associations.

Paolo’s goal as CEO of PMH is to continue investing in new technologies such as Artificial Intelligence, Machine Learning, Internet of Things and digital health. He is committed to contributing to the transformation of clinical trials through technology to support the delivery of treatments to patients faster, safer, and more cost-effective.

Angela Weston

Angela brings a wealth of experience in business development, marketing and proposal management at a global level for companies in pharmaceutical, medical device and CRO. She started her career in Healthcare before moving into Sales serving as Director of Business Development and SVP Business Development for some of the biggest players on the international Life Sciences market.

Under Angela’s direction, her team is implementing infrastructure to support effective business development and marketing strategies to enable continued company growth.

Andrea Pulvirenti_sent

Andrea started as a Project Manager for CROS NT in 2011 and was appointed as Managing Director in 2018 after holding a variety of roles in the company. He is a natural leader who strives for continuous process improvement and long-term success. Andrea possesses a degree in Engineering from Università degli Studi di Brescia (Brescia, Italy) and Executive Master’s degrees in Project Management, Corporate Finance and Business Administration (MBA). He also holds Project Management Professional (PMP) certification accredited by Project Management Institute.

Fabio Gambini_sent

Fabio is an accomplished leader with over 25 years of experience in the pharmaceutical industry. He began his career in GSK as Pre-clinical Scientist and later moved to the Medical Department where he took a role of Clinical Research Physician. In 2006, Fabio joined Amgen as Regional Medical Affairs Manager for the Oncology division later becoming Nephrology Therapeutic Area Leader & Development Operation Manager.

Prior to joining CROS NT, Fabio held the position of Onco-Haematology Medical Director at Roche, Corporate Medical Director and Market Access at Zambon Group, and Medical Director at Alexion Pharmaceuticals.

Fabio possesses a Medical Degree from Università degli Studi di Verona (Verona, Italy) and an MBA from SDA Bocconi School of Management (Milan, Italy).

Sebastien Gerin

Sébastien has a pivotal role in CROS NT as he oversees all of CROS NT’s global operations throughout Europe, North America and India. He has spent 20 years in the drug development industry before joining CROS NT. He worked on both the Sponsor and CRO side including 14 years with Merck Serono where he was global Head of Global Statistical Programming.

Experienced professional, Sébastien understands data and its importance and power to the success of clinical research. He holds a Statistics and Data Processing Degree from Université Grenoble Alpes (Grenoble, France).